U.S. Non-Glaucoma Ophthalmic Pharmaceuticals Market

 

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

This research service explores the market for prescription ophthalmics used for the treatment of ocular diseases such as age-related macular degeneration (AMD), allergic conjunctivitis, chronic dry eye, cataract, and diabetic retinopathy in the United States of America. It analyzes the various challenges faced by pharmaceutical and biotech companies, and the competitive advantages and disadvantages of their products in the market.

Table of Contents

U.S. Non-Glaucoma Ophthalmic Pharmaceuticals Market, Executive SummaryExecutive SummaryOverviewU.S. Non-Glaucoma Ophthalmic Pharmaceuticals Market, Total U.S. Non-Glaucoma Ophthalmic Pharmaceuticals MarketResearch Scope and MethodologyScope and SegmentationResearch MethodologyMarket OverviewIntroductionDisease OverviewPatient ForecastsAge-Related Macular DegenerationAllergic ConjunctivitisChronic Dry EyeNSAIDsDiabetic RetinopathyMarket TrendsIndustry Challenges and StrategiesMarket DriversU.S. Non-Glaucoma Ophthalmic Pharmaceuticals Market, Product and Pipeline AnalysisApproved Therapies and Treatment TrendsAge-Related Macular DegenerationAllergic ConjunctivitisDry-EyeNSAIDSDiabetic RetinopathyPipeline AnalysisAge Related Macular DegenerationAllergic ConjunctivitisDry-EyeNSAIDSDiabetic RetinopathyU.S. Non-Glaucoma Ophthalmic Pharmaceuticals Market, Competitive AnalysisIntroductionMarket Engineering MeasurementsPrice TrendsCompetitive StructureMarket Share and Revenue ForecastsTotal MarketAge Related Macular DegenerationAllergic ConjunctivitisDry-EyeNSAIDSU.S. Non-Glaucoma Ophthalmic Pharmaceuticals Market, AppendixDecision Support DatabasesTotal PopulationAMD PrevalenceAMD IncidenceDiabetes PrevalenceDiabetes Incidence




Related Research

Release Date : 20-Sep-17

Region : North America

Release Date : 19-Sep-17

Region : North America

Release Date : 19-Sep-17

Region : North America

Release Date : 19-Sep-17

Region : North America

Release Date : 18-Sep-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.